A Phase I Study of Decitabine (NSC 127716, IND 50733) in Combination With Doxorubicin and Cyclophosphamide in the Treatment of Relapsed or Refractory Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2013
At a glance
- Drugs Decitabine (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Neuroblastoma; Solid tumours
- Focus Adverse reactions
- 24 Oct 2007 Status changed from in progress to completed.
- 09 Aug 2005 New trial record.